Journal Article
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar,
“Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
A. Vojdani, Vojdani, E., Saidara, E., and Kharrazian, D.,
“Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
A. Vojdani, Vojdani, E., Saidara, E., and Kharrazian, D.,
“Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G.,
“Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”,
J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
C. Groot, Tolboom, N., Ikonomovic, M. D., Lammertsma, A. A., Boon, B. D. C., Barkhof, F., Scheltens, P., Klunk, W. E., Rozemuller, A. J. M., Ossenkoppele, R., and van Berckel, B. N. M.,
“Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.”,
J Alzheimers Dis, 2018.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M.,
“Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M.,
“Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
P. Liu, Reichl, J. H., Rao, E. R., McNellis, B. M., Huang, E. S., Hemmy, L. S., Forster, C. L., Kuskowski, M. A., Borchelt, D. R., Vassar, R., Ashe, K. H., and Zahs, K. R.,
“Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 743-761, 2017.
R. L. H. Handels, Sköldunger, A., Bieber, A., Edwards, R. Tudor, Gonçalves-Pereira, M., Hopper, L., Irving, K., Jelley, H., Kerpershoek, L., Marques, M. J., Meyer, G., Michelet, M., Portolani, E., Røsvik, J., Selbaek, G., Stephan, A., de Vugt, M., Wolfs, C., Woods, B., Zanetti, O., Verhey, F., and Wimo, A.,
“Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”,
J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
M. Maxime Lavallée, Gandini, D., Rouleau, I., Vallet, G. T., Joannette, M., Kergoat, M. - J., Busigny, T., Rossion, B., and Joubert, S.,
“A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1225-36, 2016.
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S.,
“Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”,
J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
C. Cressot, Vrillon, A., Lilamand, M., Francisque, H., Méauzoone, A., Hourregue, C., Dumurgier, J., Marlinge, E., Paquet, C., and Cognat, E.,
“Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”,
J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A.,
“Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”,
J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
M. I. Short, Fohner, A. E., Skjellegrind, H. K., Beiser, A., Gonzales, M. M., Satizabal, C. L., Austin, T. R., Longstreth, W. T., Bis, J. C., Lopez, O., Hveem, K., Selbæk, G., Larson, M. G., Yang, Q., Aparicio, H. J., McGrath, E. R., Gerszten, R. E., DeCarli, C. S., Psaty, B. M., Vasan, R. S., Zare, H., and Seshadri, S.,
“Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.”,
J Alzheimers Dis, vol. 96, no. 4, pp. 1767-1780, 2023.
A. F. N. Rosenberger, Hilhorst, R., Coart, E., Barrado, L. García, Naji, F., Rozemuller, A. J. M., van der Flier, W. M., Scheltens, P., Hoozemans, J. J. M., and van der Vies, S. M.,
“Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
A. F. N. Rosenberger, Hilhorst, R., Coart, E., Barrado, L. García, Naji, F., Rozemuller, A. J. M., van der Flier, W. M., Scheltens, P., Hoozemans, J. J. M., and van der Vies, S. M.,
“Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P.,
“Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
N. M. E. Scheltens, Tijms, B. M., Heymans, M. W., Rabinovici, G. D., Cohn-Sheehy, B. I., Miller, B. L., Kramer, J. H., Wolfsgruber, S., Wagner, M., Kornhuber, J., Peters, O., Scheltens, P., and van der Flier, W. M.,
“Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.”,
J Alzheimers Dis, 2018.
I. Hallikainen, Hongisto, K., Välimäki, T., Hänninen, T., Martikainen, J., and Koivisto, A. M.,
“The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.”,
J Alzheimers Dis, vol. 61, no. 4, pp. 1367-1376, 2018.
A. A. J. Gerritsen, Bakker, C., Verhey, F. R. J., Bor, H., Pijnenburg, Y. A. L., de Vugt, M. E., and Koopmans, R. T. C. M.,
“The Progression of Dementia and Cognitive Decline in a Dutch 2-Year Cohort Study of People with Young-Onset Dementia.”,
J Alzheimers Dis, vol. 63, no. 1, pp. 343-351, 2018.
D. J. Jester, Vyhnálek, M., Andel, R., Marková, H., Nikolai, T., Laczó, J., Matuskova, V., Cechova, K., Sheardova, K., and Hort, J.,
“Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance.”,
J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.
T. Voss, Kost, J., Mercer, S. Pal, Furtek, C., Randolph, C., Lines, C., Egan, M. F., and Cummings, J. L.,
“Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.”,
J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
] Year 